Finally, although our results are preliminary, they suggest that ID2 could be involved in the tumor dedifferentiation processes of NSCLC, and could be used as prognosis marker for patients with poorly differentiated tumors. This evidence concerns the gene ID2 and non-small cell lung carcinoma.